v3.25.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
Nov. 01, 2025
Nov. 02, 2024
Cash flows from operating activities:    
Net income (loss) $ 2,274.0 $ (1,085.2)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 255.2 225.5
Stock-based compensation 447.8 449.8
Amortization of acquired intangible assets 718.4 805.5
Restructuring related charges (gains), net (14.0) 524.1
Deferred income taxes (2.2) (106.2)
Gain on sale of business (1,830.4) 0.0
Other expense, net 85.1 42.1
Changes in assets and liabilities, net of acquisitions:    
Accounts receivable (518.0) 123.7
Prepaid expenses and other assets (283.5) 176.2
Inventories (19.3) (60.2)
Accounts payable (79.1) 109.8
Accrued employee compensation (68.0) 11.9
Accrued liabilities and other non-current liabilities 410.8 (49.8)
Net cash provided by operating activities 1,376.8 1,167.2
Cash flows from investing activities:    
Purchases of technology licenses (3.4) (6.2)
Purchases of property and equipment (239.8) (214.7)
Proceeds from sales of property and equipment 27.4 0.5
Acquisitions, net of cash acquired 0.0 (10.4)
Net proceeds from sale of business 2,478.6 0.0
Other, net (42.9) 0.4
Net cash provided by (used in) investing activities 2,219.9 (230.4)
Cash flows from financing activities:    
Repurchases of common stock (1,840.0) (525.0)
Proceeds from employee stock plans 51.5 52.4
Tax withholding paid on behalf of employees for net share settlement (163.4) (190.3)
Dividend payments to stockholders (154.3) (155.6)
Payments on technology license obligations (102.0) (124.4)
Proceeds from borrowings 1,198.6 0.0
Principal payments of debt (790.6) (76.6)
Other, net (30.3) 0.0
Net cash used in financing activities (1,830.5) (1,019.5)
Net increase (decrease) in cash and cash equivalents 1,766.2 (82.7)
Cash and cash equivalents at beginning of period 948.3 950.8
Cash and cash equivalents at end of period $ 2,714.5 $ 868.1

Source